 |
Vanderbilt Pharmacogenetics |
|||||||||||
|
|
The investigators listed here are all involved in various Vanderbilt Pharmacogenetics Projects. For their individual bios and information, please click on their respective names.
|
Dr Donahue oversees the component of the project which focuses on postoperative atrial fibrillation following cardiopulmonary bypass. This investigation involves data management from a large genetic repository known as the Vanderbilt Cardiac Surgery Registry. His research interests include genetic variability of the coagulation system and its impact on clinical outcomes, with focus on polymorphisms of the extrinsic pathway, platelet glycoproteins, and factor V. He is also studying the role of tissue factor pathway inhibitor in cardiopulmonary bypass.
|
|
|||||||||||
|
